ArticleFrontiers in oncology2018
Contribution of
Open access · goldAbstract read
In one paragraph
Article in Frontiers in oncology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.
0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
3.0field-weighted citation impact, top 9% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
23 citing papers in PubMed, 33 citations in OpenAlex.
- Identification of Genetic Variants Among Breast Cancer Patients and At-Risk Individuals: A Cohort Study in Sri Lanka.Breast cancer : basic and clinical research · 2026Article
- Mono-allelic MUTYH mutation as the likely inherited etiology of hereditary breast cancer in a patient from a multi-cancer family- report of a family and literature review.BMC medical genomics · 2025Review
- Prevalence of MUTYH Monoallelic Variants in Patients With Hereditary Cancer Using Multigene Panel Testing.Cancer medicine · 2025Article
- Exploring the Microbiome in Breast Cancer: The Role ofMicroorganisms · 2025Review
- Article
- Gender-Specific Genetic Predisposition to Breast Cancer:Cancers · 2024Review
- Prevalence and Distribution of MUTYH Pathogenic Variants, Is There a Relation with an Increased Risk of Breast Cancer?Cancers · 2024Article
- Exome Sequencing Reveals Novel Germline Variants in Breast Cancer Patients in the Southernmost Region of Thailand.Journal of personalized medicine · 2023Article
- Breast cancer in the era of integrating "Omics" approaches.Oncogenesis · 2022Review
- MUTYH-associated tumor syndrome: The other face of MAP.Oncogene · 2022Review
- Multi-gene panel testing increases germline predisposing mutations' detection in a cohort of breast/ovarian cancer patients from Southern Italy.Frontiers in medicine · 2022Article
- Intronic Variant of MUTYH Gene Exhibits A Strong Association with Early Onset of Breast Cancer Susceptibility in Indonesian Women Population.Asian Pacific journal of cancer prevention : APJCP · 2021Article
- Article
- Genetic Landscape of Male Breast Cancer.Cancers · 2021Review
- Male and female breast cancer: the two faces of the same genetic susceptibility coin.Breast cancer research and treatment · 2021Article
- Exome sequencing in BRCA1-2 candidate familias: the contribution of other cancer susceptibility genesFrontiers in oncology · 2021Article
- Heritable Susceptibility to Breast Cancer among African-American Women in the Detroit Research on Cancer Survivors Study.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2020Article
- Exon splicing analysis of intronic variants in multigene cancer panel testing for hereditary breast/ovarian cancer.Cancer science · 2020Article
- BeyondJournal of clinical medicine · 2020Article
- MUTYH: Not just polyposis.World journal of clinical oncology · 2020Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
26 authors at 14 institutions in 1 country.
Piera RizzoloDepartment of Molecular Medicine, Sapienza University of Rome, Rome, Italy.
Valentina SilvestriDepartment of Molecular Medicine, Sapienza University of Rome, Rome, Italy.
Agostino BucaloDepartment of Molecular Medicine, Sapienza University of Rome, Rome, Italy.
Veronica ZelliDepartment of Molecular Medicine, Sapienza University of Rome, Rome, Italy.
Virginia ValentiniDepartment of Molecular Medicine, Sapienza University of Rome, Rome, Italy.
Irene CatucciGenome Diagnostics Program, IFOM - The FIRC Institute of Molecular Oncology, Milan, Italy.
Ines ZannaCancer Risk Factors and Lifestyle Epidemiology Unit, Institute for Cancer Research, Prevention and Clinical Network (ISPRO), Florence, Italy.
Giovanna MasalaCancer Risk Factors and Lifestyle Epidemiology Unit, Institute for Cancer Research, Prevention and Clinical Network (ISPRO), Florence, Italy.
Simonetta BianchiDivision of Pathological Anatomy, Department of Surgery and Translational Medicine, University of Florence, Florence, Italy.
Alessandro Mauro SpinelliInstitute for Maternal and Child Health IRCCS Burlo Garofolo, Trieste, Italy.
Stefania TommasiMolecular Genetics Laboratory, Istituto Tumori Giovanni Paolo II, Bari, Italy.
Maria Grazia TibilettiDipartimento di Patologia, ASST Settelaghi and Centro di Ricerca per lo studio dei tumori eredo-familiari, Università dell'Insubria, Varese, Italy.
Antonio RussoSection of Medical Oncology, Department of Surgical and Oncological Sciences, University of Palermo, Palermo, Italy.
Liliana VarescoIRCCS Ospedale Policlinico San Martino, Genoa, Italy.
Anna CoppaDepartment of Experimental Medicine, Sapienza University of Rome, Rome, Italy.
Daniele CalistriIstituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST), Meldola, Italy.
Laura CortesiDepartment of Oncology and Haematology, University of Modena and Reggio Emilia, Modena, Italy.
Alessandra VielUnità di Oncogenetica e Oncogenomica Funzionale, Centro di Riferimento Oncologico di Aviano (CRO), IRCCS, Aviano, Italy.
Bernardo BonanniDivision of Cancer Prevention and Genetics, European Institute of Oncology (IEO), IRCCS, Milan, Italy.
Jacopo AzzolliniUnità di Genetica Medica, Dipartimento di Oncologia Medica ed Ematologia, Fondazione IRCCS Istituto Nazionale dei Tumori (INT), Milan, Italy.
Siranoush ManoukianUnità di Genetica Medica, Dipartimento di Oncologia Medica ed Ematologia, Fondazione IRCCS Istituto Nazionale dei Tumori (INT), Milan, Italy.
Marco MontagnaImmunology and Molecular Oncology Unit, Veneto Institute of Oncology IOV - IRCCS, Padua, Italy.
Paolo RadiceUnità di Ricerca Medicina Predittiva: Basi molecolari Rischio genetico e Test genetici, Dipartimento di Ricerca, Fondazione IRCCS Istituto Nazionale Tumori (INT), Milan, Italy.
Domenico PalliCancer Risk Factors and Lifestyle Epidemiology Unit, Institute for Cancer Research, Prevention and Clinical Network (ISPRO), Florence, Italy.
Paolo PeterlongoGenome Diagnostics Program, IFOM - The FIRC Institute of Molecular Oncology, Milan, Italy.
Laura OttiniDepartment of Molecular Medicine, Sapienza University of Rome, Rome, Italy.
Sapienza University of Rome · ITFondazione IRCCS Istituto Nazionale dei Tumori · ITPiedmont Reference Center for Epidemiology and Cancer Prevention · ITFIRC Institute of Molecular Oncology · ITIstituti di Ricovero e Cura a Carattere Scientifico · ITEuropean Institute of Oncology · ITIRCCS Materno Infantile Burlo Garofolo · ITIstituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori · ITIstituto Tumori Bari · ITOspedale Policlinico San Martino · ITUniversity of Florence · ITUniversity of Insubria · ITUniversity of Modena and Reggio Emilia · ITUniversity of Palermo · IT
Funding
No grant is acknowledged in the PubMed record.
Abstract
Inherited mutations in
Indexed as
BRCA1/2breast cancer riskgenetic susceptibilitymale breast cancerMUTYHMUTYH-associated polyposis (MAP) syndromeNGS
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.